We are live on ! Find out more
LAB icon

Standard BioTools
LAB

160 hedge funds and large institutions have $337M invested in Standard BioTools in 2025 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 47 increasing their positions, 45 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

142% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 12

39% more call options, than puts

Call options by funds: $68K | Put options by funds: $49K

10% more funds holding

Funds holding: 145 → 160 (+15)

9% more capital invested

Capital invested by funds: $308M → $337M (+$29M)

4% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 45

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

1.29% less ownership

Funds ownership: 75.16% → 73.87% (-1.3%)

Holders
160
Holders Change
+15
Holders Change %
+10.34%
% of All Funds
2.11%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
29
Increased
47
Reduced
45
Closed
12
Calls
$68K
Puts
$49K
Net Calls
+$19K
Net Calls Change
+$75K

Top Buyers

Rank Fund Capital Flow
1
LFCM
Long Focus Capital Management
Puerto Rico
+$3.74M
2
MCO
MAK Capital One
New York
+$3.13M
3
KLP
Kent Lake PR
Puerto Rico
+$1.11M
4
Goldman Sachs
Goldman Sachs
New York
+$712K
5
RA
Royce & Associates
New York
+$706K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$4.97M
2
MFS
Mirabella Financial Services
United Kingdom
-$3.44M
3
Millennium Management
Millennium Management
New York
-$3.01M
4
TM
Tikvah Management
North Carolina
-$1.66M
5
Primecap Management
Primecap Management
California
-$381K
Name Holding Trade Value Shares
Change 		Change in
Stake
KLP
26
Kent Lake PR
Puerto Rico
$1.2M +$1.11M +1,000,000 New
Bank of New York Mellon
27
Bank of New York Mellon
New York
$933K +$49.7K +44,868 +6%
UBS AM
28
UBS AM
Illinois
$892K +$210K +189,469 +34%
N
29
Nuveen
North Carolina
$789K -$157K -141,270 -18%
AQR Capital Management
30
AQR Capital Management
Connecticut
$734K +$143K +129,151 +27%
RhumbLine Advisers
31
RhumbLine Advisers
Massachusetts
$568K +$66.8K +60,220 +15%
Swiss National Bank
32
Swiss National Bank
Switzerland
$565K +$36.2K +32,700 +7%
Qube Research & Technologies (QRT)
33
Qube Research & Technologies (QRT)
United Kingdom
$529K +$23.3K +20,979 +5%
NIM
34
Needham Investment Management
New York
$521K -$111K -100,000 -19%
TCM
35
Tang Capital Management
California
$489K – – –
IP
36
Intellectus Partners
California
$486K – – –
Susquehanna International Group
37
Susquehanna International Group
Pennsylvania
$479K +$19.3K +17,400 +5%
UBS Group
38
UBS Group
Switzerland
$453K -$32.3K -29,117 -7%
Citadel Advisors
39
Citadel Advisors
Florida
$419K +$387K +349,160 New
Rockefeller Capital Management
40
Rockefeller Capital Management
New York
$409K +$18.3K +16,544 +5%
AllianceBernstein
41
AllianceBernstein
Tennessee
$379K – – –
Legal & General Group
42
Legal & General Group
United Kingdom
$373K +$70.4K +63,484 +26%
JJ
43
Johnson & Johnson
New Jersey
$371K – – –
GCP
44
GSA Capital Partners
United Kingdom
$368K -$335K -302,169 -50%
Primecap Management
45
Primecap Management
California
$347K -$381K -343,300 -54%
HighTower Advisors
46
HighTower Advisors
Illinois
$269K +$135K +121,422 +118%
Deutsche Bank
47
Deutsche Bank
Germany
$261K -$16.7K -15,099 -6%
T. Rowe Price Associates
48
T. Rowe Price Associates
Maryland
$252K +$15.7K +14,193 +7%
Wells Fargo
49
Wells Fargo
California
$247K +$25.1K +22,640 +12%
GAG
50
GM Advisory Group
New York
$240K – – –
1
2
3 4 5

LAB Hedge Fund Activity: Q2 2025 in Review

160 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q2 2025, worth a combined $337M — up 9.4% from $308M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new LAB positions and 12 closed out — a net gain of 17 holders — while 47 added to existing stakes and 45 trimmed.

The largest buyer was Long Focus Capital Management, adding an estimated $3.74M. The largest seller was Morgan Stanley, cutting an estimated $4.97M.

  • 160 institutional investors held Standard BioTools (LAB) as of Q2 2025, up from 145 in Q1 2025.
  • Funds reported $337M of Standard BioTools stock for Q2 2025, up 9.4% quarter-over-quarter.
  • 29 funds opened new Standard BioTools positions in Q2 2025 and 12 closed out, a net change of +17 holders.
  • The largest Standard BioTools buyer in Q2 2025 was Long Focus Capital Management, an estimated $3.74M added.
  • The largest Standard BioTools seller in Q2 2025 was Morgan Stanley, an estimated $4.97M sold.

Based on aggregated 13F filings for Q2 2025.